Skip to main content
Erschienen in: Medical Oncology 1/2011

01.12.2011

Activity of trabectidin in desmoplastic small round cell tumor

verfasst von: Ana López-González, Blanca Cantos, Eva Tejerina, Mariano Provencio

Erschienen in: Medical Oncology | Sonderheft 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Desmoplastic small round cell tumor (DSRCT) is a rare and aggressive cancer that typically arises in teenage boys. As a result of its low prevalence, there have been few studies of its treatment and impact on survival. Here, we report the case of a patient who was refractory to multiple drugs but remains stable with trabectedin. To our knowledge, this is the first published report that supports antitumoral activity of trabectedin in DSRCT.
Literatur
1.
Zurück zum Zitat Stuart-Buttle CE, Smart CJ, Pritchard S, Martin D, Welch IM. Desmoplastic small round cell tumour: a review of literature and treatment options. Surg Oncol. 2008;17(2):107–12.PubMedCrossRef Stuart-Buttle CE, Smart CJ, Pritchard S, Martin D, Welch IM. Desmoplastic small round cell tumour: a review of literature and treatment options. Surg Oncol. 2008;17(2):107–12.PubMedCrossRef
2.
Zurück zum Zitat Tejerina González E, Corbacho Cuevas C, López García A, Bellas C, Sánchez V, Sánchez Ruiz A, de Álava E, Sanz E. Tumor intraabdominal desmoplásico de células pequeñas y redondas. Revisión de la literatura a propósito de un caso con estudio citológico, histopatológico, inmunohistoquímico y molecular. Oncología. 2007;30(1):25–31. Tejerina González E, Corbacho Cuevas C, López García A, Bellas C, Sánchez V, Sánchez Ruiz A, de Álava E, Sanz E. Tumor intraabdominal desmoplásico de células pequeñas y redondas. Revisión de la literatura a propósito de un caso con estudio citológico, histopatológico, inmunohistoquímico y molecular. Oncología. 2007;30(1):25–31.
3.
Zurück zum Zitat Landayi M, Gerald W. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumors. Cancer Res. 1994;54:2837–40. Landayi M, Gerald W. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumors. Cancer Res. 1994;54:2837–40.
4.
Zurück zum Zitat Hassan I, et al. Intraabdominal desmoplastic small round cell tumours—a diagnostic and therapeutic challenge. Cancer. 2005;104(6):1264–70.PubMedCrossRef Hassan I, et al. Intraabdominal desmoplastic small round cell tumours—a diagnostic and therapeutic challenge. Cancer. 2005;104(6):1264–70.PubMedCrossRef
5.
Zurück zum Zitat Livaditi E, Mavridis G, Soutis M, et al. Diffuse intraabdominal desmoplastic small round cell tumour: a ten-year experience. Eur J Pediatr Surg. 2006;16(6):423–7.PubMedCrossRef Livaditi E, Mavridis G, Soutis M, et al. Diffuse intraabdominal desmoplastic small round cell tumour: a ten-year experience. Eur J Pediatr Surg. 2006;16(6):423–7.PubMedCrossRef
6.
Zurück zum Zitat Herrero AB, Martín-Castellanos C, Marco E, Gago F, Moreno S. Cross-talk between nucleotide excision and homologous recombination DNA repair pathways in the mechanism of action of antitumor trabectedin. Cancer Res. 2006;66(16):8155–62.PubMedCrossRef Herrero AB, Martín-Castellanos C, Marco E, Gago F, Moreno S. Cross-talk between nucleotide excision and homologous recombination DNA repair pathways in the mechanism of action of antitumor trabectedin. Cancer Res. 2006;66(16):8155–62.PubMedCrossRef
7.
Zurück zum Zitat Grosso F, et al. Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study. Lancet Oncol. 2007;8:595–602.PubMedCrossRef Grosso F, et al. Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study. Lancet Oncol. 2007;8:595–602.PubMedCrossRef
8.
Zurück zum Zitat Grosso F, et al. Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series. Ann Oncol. 2009;20(8):1439–44.PubMedCrossRef Grosso F, et al. Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series. Ann Oncol. 2009;20(8):1439–44.PubMedCrossRef
9.
Zurück zum Zitat Bonfanti M, La Valle E, Fernández Sousa-Faro JM, Faircloth G, Caretti G, Mantonvani R, D’Incalci M. Effect of ecteinascidin-743 on the interaction between DNA binding proteins and DNA. Anticancer Drug Des. 1999;14:179–86.PubMed Bonfanti M, La Valle E, Fernández Sousa-Faro JM, Faircloth G, Caretti G, Mantonvani R, D’Incalci M. Effect of ecteinascidin-743 on the interaction between DNA binding proteins and DNA. Anticancer Drug Des. 1999;14:179–86.PubMed
10.
Zurück zum Zitat Forni C, et al. Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors. Mol Cancer Ther. 2009;8(2):449–57.PubMedCrossRef Forni C, et al. Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors. Mol Cancer Ther. 2009;8(2):449–57.PubMedCrossRef
11.
Zurück zum Zitat Tavecchio M, et al. Dynamics of cell cycle phase perturbations by trabectedin (ET-743) in nucleotide excision repair (NER)-deficient and NER-proficient cells, unravelled by a novel mathematical simulation approach. Cell Prolif. 2007;40:885–904.PubMedCrossRef Tavecchio M, et al. Dynamics of cell cycle phase perturbations by trabectedin (ET-743) in nucleotide excision repair (NER)-deficient and NER-proficient cells, unravelled by a novel mathematical simulation approach. Cell Prolif. 2007;40:885–904.PubMedCrossRef
12.
Zurück zum Zitat Tavecchio M, et al. Role of homologous recombination in trabectedin-induced DNA damage. Eur J Cancer. 2008;44:609–18.PubMedCrossRef Tavecchio M, et al. Role of homologous recombination in trabectedin-induced DNA damage. Eur J Cancer. 2008;44:609–18.PubMedCrossRef
13.
Zurück zum Zitat Soares DG, et al. Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743. PNAS. 2007;104(32):13062–7.PubMedCrossRef Soares DG, et al. Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743. PNAS. 2007;104(32):13062–7.PubMedCrossRef
Metadaten
Titel
Activity of trabectidin in desmoplastic small round cell tumor
verfasst von
Ana López-González
Blanca Cantos
Eva Tejerina
Mariano Provencio
Publikationsdatum
01.12.2011
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe Sonderheft 1/2011
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9687-9

Weitere Artikel der Sonderheft 1/2011

Medical Oncology 1/2011 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.